A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
暂无分享,去创建一个
C. Huard | M. Evans | R. Martinez | S. Gardell | P. Mahaney | J. A. Krueger | G. Vlasuk | D. Harnish | Shuguang Wang | L. Borges-Marcucci | K. Lai | Kehdih Lai